Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Six-month open-label follow-up of risperidone long-acting injection use in pediatric bipolar disorder.

Boarati MA, Wang YP, Ferreira-Maia AP, Cavalcanti AR, Fu-I L.

Prim Care Companion CNS Disord. 2013;15(3). pii: PCC.12m01368. doi: 10.4088/PCC.12m01368. Epub 2013 May 2.

PMID:
24171144
[PubMed]
Free PMC Article
2.

Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.

Macfadden W, Adler CM, Turkoz I, Haskins JT, Turner N, Alphs L.

BMC Psychiatry. 2011 Oct 28;11:171. doi: 10.1186/1471-244X-11-171.

PMID:
22034906
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
4.

Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.

Rosa F, Schreiner A, Thomas P, Sherif T.

Clin Drug Investig. 2012 Apr 1;32(4):267-79. doi: 10.2165/11599080-000000000-00000.

PMID:
22339430
[PubMed - indexed for MEDLINE]
5.

Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder.

Han C, Lee MS, Pae CU, Ko YH, Patkar AA, Jung IK.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1219-23. Epub 2007 May 1.

PMID:
17532106
[PubMed - indexed for MEDLINE]
6.

Use of risperidone long-acting injectable in a rural border community clinic in southern california.

Camacho A, Ng B, Galangue B, Feifel D.

Psychiatry (Edgmont). 2008 Jun;5(6):43-9.

PMID:
19727284
[PubMed]
Free PMC Article
7.

Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.

Taylor DM, Young CL, Mace S, Patel MX.

J Clin Psychiatry. 2004 Aug;65(8):1076-83.

PMID:
15323592
[PubMed - indexed for MEDLINE]
8.

Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.

Bobo WV, Shelton RC.

Expert Rev Neurother. 2010 Nov;10(11):1637-58. doi: 10.1586/ern.10.143. Review.

PMID:
20977322
[PubMed - indexed for MEDLINE]
9.

A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.

Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM.

J Clin Psychiatry. 2009 Oct;70(10):1397-406. doi: 10.4088/JCP.09m05284yel.

PMID:
19906343
[PubMed - indexed for MEDLINE]
10.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
[PubMed - indexed for MEDLINE]
11.

Maintenance treatment with long-acting injectable risperidone in first-episode schizophrenia: a randomized effectiveness study.

Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa-McMillan A.

J Clin Psychiatry. 2012 Sep;73(9):1224-33. doi: 10.4088/JCP.11m06905. Epub 2012 Aug 7.

PMID:
22938760
[PubMed - indexed for MEDLINE]
12.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
[PubMed - indexed for MEDLINE]
13.

Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries.

Peuskens J, Olivares JM, Pecenak J, Tuma I, Bij de Weg H, Eriksson L, Resseler S, Akhras K, Jacobs A.

Curr Med Res Opin. 2010 Mar;26(3):501-9. doi: 10.1185/03007990903488670.

PMID:
20014981
[PubMed - indexed for MEDLINE]
14.

Risperidone long-acting injection (RLAI): the 12-week efficacy and tolerability in Thai patients with chronic schizophrenia.

Arunpongpaisal S, Srisurapanont M, Kongsakon R, Kitiwattanagul K, Samanwongthai U.

J Med Assoc Thai. 2010 Mar;93(3):343-50.

PMID:
20420110
[PubMed - indexed for MEDLINE]
15.
16.

Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.

Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG; Risperidone Long-Acting Trial Investigators (R-LAI).

Hum Psychopharmacol. 2009 Oct;24(7):574-83. doi: 10.1002/hup.1067.

PMID:
19790173
[PubMed - indexed for MEDLINE]
17.

Risperidone long-acting injection in the treatment of schizophrenia spectrum illnesses: A retrospective chart review of 19 patients in the Vancouver Community Mental Health Organization (Vancouver, Canada).

Ganesan S, McKenna M, Procyshyn RM, Zipursky S.

Curr Ther Res Clin Exp. 2007 Nov;68(6):409-20. doi: 10.1016/j.curtheres.2007.12.002. Erratum in: Curr Ther Res Clin Exp. 2008 Feb;69(1):101.

PMID:
24692772
[PubMed]
Free PMC Article
18.

Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders.

Parellada E, Kouniakis F, Siurkute A, Schreiner A, Don L.

Int Clin Psychopharmacol. 2010 May;25(3):149-54. doi: 10.1097/YIC.0b013e328336c93f.

PMID:
20305567
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).

Vieta E, Herraiz M, Fernández A, Gastó C, Benabarre A, Colom F, Martínez-Arán A, Reinares M.

J Clin Psychiatry. 2001 Aug;62(8):623-30.

PMID:
11561935
[PubMed - indexed for MEDLINE]
20.

A descriptive, open-label, long-term follow-up survey of psychotic patients receiving risperidone long-acting injectable: Preliminary results.

Viala A, Cornic F, Benamor C, Baldacci C, Cheref S, Gauillard J, Martin P, Caroli F, Vacheron MN.

Int J Psychiatry Clin Pract. 2009;13(2):138-46. doi: 10.1080/13651500802570980.

PMID:
24916733
[PubMed]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk